AIM IMMUNOTECH INC. Long-term Debt, Gross
AIM IMMUNOTECH INC. (AIM) had Long-term Debt, Gross of $4.07 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2026-08-07
- 2026-06-30: Long-term Debt, Gross $4.07M.
- 2026-03-31: Long-term Debt, Gross $4.84M.
- 2025-12-31: Long-term Debt, Gross $5.29M.
- 2024-12-31: Long-term Debt, Gross $2.81M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2026-06-30 | $4.07M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $4.84M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $5.29M 10-Q · filed 2026-08-07 |
| 2024-12-31 | $2.81M 10-K · filed 2026-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |